Company Profile
Syros Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- SYRS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.00 USD (0.00%)
Close
Last updated: August 6, 2026
—
Market cap
Why the stock is moving
As of Aug 6, 2026, SYRS was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
Company overview
Business overview
Syros Pharmaceuticals is a precision-oncology company focused on gene regulation and transcriptional control in cancer. Its platform targets the biology that drives tumor growth and resistance.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Syros sits in specialty oncology biotechnology.
Business Model Characteristics
The company depends on clinical data, target validation, and the ability to create a durable oncology story.
Position Within the Biotechnology Landscape
Syros is a small-cap oncology catalyst name whose valuation depends on early data and strategic progress.
Future catalysts
Syros’s catalysts are tamibarotene-related oncology updates and any strategic step that clarifies the company’s future. The story remains dependent on whether there is still enough clinical value left.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Syros Pharmaceuticals (SYRS)?
Syros Pharmaceuticals (SYRS) most recently closed at 0.00 USD, a 0.00% move versus the previous session.
What does Syros Pharmaceuticals do?
Syros Pharmaceuticals is a precision-oncology company focused on gene regulation and transcriptional control in cancer. Its platform targets the biology that drives tumor growth and resistance.
On which exchange is SYRS stock listed?
Syros Pharmaceuticals (SYRS) is associated with NASDAQ, United States, Biopharma.
What is Syros?
Syros’s catalysts are tamibarotene-related oncology updates and any strategic step that clarifies the company’s future.
Which conditions is Syros Pharmaceuticals targeting with Syros?
Syros Pharmaceuticals is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Syros Pharmaceuticals describe recent progress with Syros?
Syros’s catalysts are tamibarotene-related oncology updates and any strategic step that clarifies the company’s future.
What is Pharmaceuticals?
Syros Pharmaceuticals is a precision-oncology company focused on gene regulation and transcriptional control in cancer.
What should investors watch for with Pharmaceuticals?
Syros’s catalysts are tamibarotene-related oncology updates and any strategic step that clarifies the company’s future. The story remains dependent on whether there is still enough clinical value left.